|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM211346543 |
| 003 |
DE-627 |
| 005 |
20250213052601.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231224s2011 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1155/2011/723184
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n0704.xml
|
| 035 |
|
|
|a (DE-627)NLM211346543
|
| 035 |
|
|
|a (NLM)21904685
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Gonzalez-Burgos, Guillermo
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia
|
| 264 |
|
1 |
|c 2011
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 04.01.2012
|
| 500 |
|
|
|a Date Revised 18.03.2022
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Schizophrenia is a brain disorder associated with cognitive deficits that severely affect the patients' capacity for daily functioning. Whereas our understanding of its pathophysiology is limited, postmortem studies suggest that schizophrenia is associated with deficits of GABA-mediated synaptic transmission. A major role of GABA-mediated transmission may be producing synchronized network oscillations which are currently hypothesized to be essential for normal cognitive function. Therefore, cognitive deficits in schizophrenia may result from a GABA synapse dysfunction that disturbs neural synchrony. Here, we highlight recent studies further suggesting alterations of GABA transmission and network oscillations in schizophrenia. We also review current models for the mechanisms of GABA-mediated synchronization of neural activity, focusing on parvalbumin-positive GABA neurons, which are altered in schizophrenia and whose function has been strongly linked to the production of neural synchrony. Alterations of GABA signaling that impair gamma oscillations and, as a result, cognitive function suggest paths for novel therapeutic interventions
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, N.I.H., Extramural
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
7 |
|a Parvalbumins
|2 NLM
|
| 650 |
|
7 |
|a Receptors, GABA-A
|2 NLM
|
| 650 |
|
7 |
|a gamma-Aminobutyric Acid
|2 NLM
|
| 650 |
|
7 |
|a 56-12-2
|2 NLM
|
| 700 |
1 |
|
|a Fish, Kenneth N
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lewis, David A
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Neural plasticity
|d 1998
|g 2011(2011) vom: 13., Seite 723184
|w (DE-627)NLM098558390
|x 1687-5443
|7 nnas
|
| 773 |
1 |
8 |
|g volume:2011
|g year:2011
|g day:13
|g pages:723184
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1155/2011/723184
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_21
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 2011
|j 2011
|b 13
|h 723184
|